Anticoagulation therapy for stroke prevention in atrial fibrillation : (Record no. 414)
| 000 -LEADER | |
|---|---|
| fixed length control field | 00619cas a2200169 a 4500 |
| 001 - CONTROL NUMBER | |
| control field | J-000379 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120123s9999 xx r poo 0 0eng d |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Go, A. |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hyler, E. |
| 222 #0 - KEY TITLE | |
| Key title | JAMA |
| 245 00 - TITLE STATEMENT | |
| Title | Anticoagulation therapy for stroke prevention in atrial fibrillation : |
| Remainder of title | how well do randomised trials translate into clinical practice |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2685-2692 |
| 500 ## - GENERAL NOTE | |
| General note | Journal print article |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc | Warfarin is very effective for preventing ischemic strokes. 3 tabs. 1 fig. 47 refs. |
| 650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cerebrovascular disorders |
| General subdivision | Primary prevention |
| -- | Warfarin |
| -- | Anticoagulants |
| Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Serial Enumeration / chronology | Date last seen | Copy number | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BHPI CRP LIbrary | BHPI CRP LIbrary | 2013-05-25 | 290, 20, 26 November, 2003 | 2013-05-25 | 1 | 2013-05-25 | Journals, eBooks, Papers, Articles, Magazines |